Submission Details
| 510(k) Number | K161513 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | June 02, 2016 |
| Decision Date | August 25, 2016 |
| Days to Decision | 84 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Statement |
K161513 is an FDA 510(k) clearance for the Anti-Borrelia burgdorferi US Westernblot (IgG), a Reagent, Borrelia Serological Reagent (Class II — Special Controls, product code LSR), submitted by Euroimmun US (Morris Plains, US). The FDA issued a Cleared decision on August 25, 2016, 84 days after receiving the submission on June 2, 2016. This device falls under the Microbiology review panel. Regulated under 21 CFR 866.3830.
| 510(k) Number | K161513 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | June 02, 2016 |
| Decision Date | August 25, 2016 |
| Days to Decision | 84 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Statement |
| Product Code | LSR — Reagent, Borrelia Serological Reagent |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 866.3830 |